Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jurgen Venitz

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Drug Development and Industrial Pharmacy|May 14, 2003
Comparison of neural network and multiple linear regression as dissolution predictorsPradeep M Sathe, Jurgen Venitz
Expert Opinion on Drug Metabolism & Toxicology|March 23, 2012
Fluoroquinolone disposition: identification of the contribution of renal secretory and reabsorptive drug transportersAditi Mulgaonkar, Jurgen Venitz, Douglas H Sweet
Biopharmaceutics & Drug Disposition|December 7, 2018
Use of generally recognized as safe or dietary compounds to inhibit buprenorphine metabolism: potential to improve buprenorphine oral bioavailabilityNeha Maharao, Jurgen Venitz, Phillip M Gerk
Journal of Pharmaceutical Sciences|February 9, 2002
Solute disposition in the rat lung in vivo and in vitro: determining regional absorption kinetics in the presence of mucociliary escalatorMasahiro Sakagami, Peter R Byron, Jurgen Venitz, et al.
Pharmacotherapy|February 18, 2003
2-Methoxyestradiol, a promising anticancer agentNehal J Lakhani, Mohamadi A Sarkar, Jurgen Venitz, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|October 9, 2015
In Vitro Tests for Aerosol Deposition. IV: Simulating Variations in Human Breath Profiles for Realistic DPI TestingRenishkumar R Delvadia, Xiangyin Wei, P Worth Longest, et al.
Muscle & Nerve|October 23, 2021
Identifying a patient-centered outcome measure for a comparative effectiveness treatment trial in myasthenia gravisPushpa Narayanaswami, Donald B Sanders, Kathie Bibeau, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
A theoretical model for the effects of reduced hemoglobin-oxygen affinity on tumor oxygenationBrian D Kavanagh, Timothy W Secomb, Richard Hsu, et al.
Muscle & Nerve|February 24, 2015
Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United StatesTed M Burns, Donald B Sanders, Henry J Kaminski, et al.
Cancer Metastasis Reviews|October 29, 2002
Antiangiogenesis therapeutic strategies in prostate cancerGordon R Macpherson, Sylvia S W Ng, Nehal J Lakhani, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Drug Development and Industrial Pharmacy|May 14, 2003
Comparison of neural network and multiple linear regression as dissolution predictorsPradeep M Sathe, Jurgen Venitz
Expert Opinion on Drug Metabolism & Toxicology|March 23, 2012
Fluoroquinolone disposition: identification of the contribution of renal secretory and reabsorptive drug transportersAditi Mulgaonkar, Jurgen Venitz, Douglas H Sweet
Biopharmaceutics & Drug Disposition|December 7, 2018
Use of generally recognized as safe or dietary compounds to inhibit buprenorphine metabolism: potential to improve buprenorphine oral bioavailabilityNeha Maharao, Jurgen Venitz, Phillip M Gerk
Journal of Pharmaceutical Sciences|February 9, 2002
Solute disposition in the rat lung in vivo and in vitro: determining regional absorption kinetics in the presence of mucociliary escalatorMasahiro Sakagami, Peter R Byron, Jurgen Venitz, et al.
Pharmacotherapy|February 18, 2003
2-Methoxyestradiol, a promising anticancer agentNehal J Lakhani, Mohamadi A Sarkar, Jurgen Venitz, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|October 9, 2015
In Vitro Tests for Aerosol Deposition. IV: Simulating Variations in Human Breath Profiles for Realistic DPI TestingRenishkumar R Delvadia, Xiangyin Wei, P Worth Longest, et al.
Muscle & Nerve|October 23, 2021
Identifying a patient-centered outcome measure for a comparative effectiveness treatment trial in myasthenia gravisPushpa Narayanaswami, Donald B Sanders, Kathie Bibeau, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
A theoretical model for the effects of reduced hemoglobin-oxygen affinity on tumor oxygenationBrian D Kavanagh, Timothy W Secomb, Richard Hsu, et al.
Muscle & Nerve|February 24, 2015
Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United StatesTed M Burns, Donald B Sanders, Henry J Kaminski, et al.
Cancer Metastasis Reviews|October 29, 2002
Antiangiogenesis therapeutic strategies in prostate cancerGordon R Macpherson, Sylvia S W Ng, Nehal J Lakhani, et al.
Pageof 2